{
    "Trade/Device Name(s)": [
        "IgX PLEXTM Rheumatoid Arthritis Qualitative Assay",
        "SQiDworksTM Diagnostics Platform"
    ],
    "Submitter Information": "SQI Diagnostics Systems, Inc.",
    "510(k) Number": "K083080",
    "Predicate Device Reference 510(k) Number(s)": [
        "K983084",
        "K971614",
        "K052264",
        "K041658"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHR",
        "NHX",
        "NSU"
    ],
    "Summary Letter Date": "October 9, 2009",
    "Summary Letter Received Date": "October 13, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5775",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Rheumatoid Factor Immunological System",
        "Instrumentation for Clinical Multiplex Test"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "Rheumatoid Factor IgA",
        "Rheumatoid Factor IgM",
        "Cyclic Citrullinated Peptide IgG (CCP IgG)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        "2.0 mL tube",
        "Translucent bottle",
        "Foil package",
        "Amber bottle",
        "CD-ROM (for documentation)"
    ],
    "Instrument(s)/Platform(s)": [
        "SQiDworksTM Diagnostics Platform"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex microarray-based fluorescent detection"
    ],
    "Methodologies": [
        "Microarray",
        "Fluorescence immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Platform",
        "Reagent",
        "Calibrator",
        "Control",
        "Software",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for IgX PLEXTM Rheumatoid Arthritis Qualitative Assay and SQiDworksTM Diagnostics Platform for qualitative detection of RF IgA/IgM and anti-CCP IgG in human serum using multiplex microarray fluorescence technology.",
    "Indications for Use Summary": "Intended for qualitative detection of IgA and IgM Rheumatoid Factors and IgG anti-cyclic citrullinated peptide antibodies in human serum as an aid in the diagnosis of Rheumatoid Arthritis, for use in clinical laboratories and requiring the SQiDworksTM Diagnostics Platform.",
    "fda_folder": "Immunology"
}